@FierceMedDev: Medtronic appears to be negotiating with Indian device giant Trivitron Healthcare for a "strategic investment." More | Follow @FierceMedDev
@MarkHFierce: U.K. Sanofi site draws $7.8M investment for asthma inhaler production. Item | Follow @MarkHFierce
@DamianFierce: Quest Dx and LabCorp are scaling back expectations after a tepid Q2. More | Follow @DamianFierce
> Should companies be legally allowed in the U.S. to obtain patents on genetic material, and on procedures that use that material for both medical diagnoses and treatments? A federal court will begin hearing arguments on the matter this week, Bloomberg reports. Story
> Baxter ($BAX) expects sales growth to reach 5-6% in its 2012 third quarter, excluding the impact of foreign currency, and earnings per diluted share of $1.12 to $1.14 before any special items. Release
> The FDA's new device ID plan is meant to keep patients safe, but will it work? Article
> The FDA has cleared pSivida's ($PSDV) investigational new drug application to treat posterior uveitis with its injectable sustained-release micro-insert, which means the company will advance to two Phase II trials to treat patients with posterior uveitis, enrolling 300 patients. Release
> Canada's Verisante Technology is gearing up for the commercial launch of new skin cancer diagnostic technology. Release
> Stanford's Henry Miller says the growing regulatory burden in the U.S. will force devicemakers to move their R&D and manufacturing operations overseas. Column
> AorTech, the company that manufactures polymer coatings for St. Jude Medical's ($STJ) Durata leads, is up for sale. Report
> Tornier in The Netherlands has appointed Shawn T. McCormick as its new chief financial officer as of Sept. 4, 2012. McCormick is a veteran medical device executive who previously served various leadership roles at Medtronic, ev3 and Lutonix. Release
Biotech News
@FierceBiotech: Study: Low-income patients less likely to join cancer trials. Report | Follow @FierceBiotech
@JohnCFierce: Interesting approach--super high risk; EnVivo grabs Alzheimer's spotlight with promising PhIIb results. News | Follow @JohnCFierce
@RyanMFierce: Innovation in pharma manufacturing is under-appreciated. Thinking about this as I cover Novartis' woes at Lincoln, NE plant. Hurt Q2 sales. | Follow @RyanMFierce
> Faded star at Pfizer leads to discounted $68M IPO for Durata. Article
> Infinity restructures drug deal, raises $27.5M as it scrambles to refocus. News
> Multibillion-dollar R&D strategy is paying off for Novartis. More
Pharma News
@FiercePharma: PDI expects $57M from deal to market 'newly FDA approved drug'. Vivus diet pill Qsymia, maybe? Release | Follow @FiercePharma
> New bill aims to mandate abuse-deterrent painkillers. Report
> Novartis leans on emerging markets, new meds to offset Diovan drop. News
> Plavix tops U.S. sales ranks, but not for long. More
CRO News
> Medpace adds clinical pharma unit for PhI trials. Story
> ScinoPharm will manufacture blockbuster hopeful Qsymia. Article
> Europe moves toward liberalizing clinical trial rules. More
> Study: Low-income patients less likely to join cancer trials. Report
> Indian regulators shutter 12 drug plants over enviro concerns. News
Vaccines News
> Galena stock jumps with NeuVax patent. Report
> Oral vax rides on advanced microparticles. News
> Silk could eliminate 'cold chain' need. Story
> MedImmune to cut 200 jobs, layoffs hit vax R&D. Article
> University of Birmingham explores attitudes toward polio vax in India. More
> HIV-positive patients approved for smallpox vax in an emergency. Item
Pharma Manufacturing News
> Novartis's Q2 sales hit after Excedrin production woes. News
> Sanofi plant adds 40 to produce SkyePharma product. More
> Docs reportedly get smuggled cancer drugs in Pakistan bazaar. Story
> J&J 'decree' upgrades cost 200 jobs in Puerto Rico. Article